Kiang Mathew V, Bubar Kate M, Maldonado Yvonne, Hotez Peter J, Lo Nathan C
Department of Epidemiology and Population Health, Stanford University, Stanford, California.
Division of Infectious Diseases and Geographic Medicine, Department of Medicine, Stanford University, Stanford, California.
JAMA. 2025 Apr 24. doi: 10.1001/jama.2025.6495.
Widespread childhood vaccination has eliminated many infectious diseases in the US. However, vaccination rates are declining, and there are ongoing policy debates to reduce the childhood vaccine schedule, which may risk reemergence of previously eliminated infectious diseases.
To estimate the number of cases and complications in the US under scenarios of declining childhood vaccination for measles, rubella, poliomyelitis, and diphtheria.
DESIGN, SETTING, AND PARTICIPANTS: A simulation model was used to assess the importation and dynamic spread of vaccine-preventable infectious diseases across 50 US states and the District of Columbia. The model was parameterized with data on area-specific estimates for demography, population immunity, and infectious disease importation risk. The model evaluated scenarios with different vaccination rates over a 25-year period. Inputs for current childhood vaccination rates were based on 2004-2023 data.
The primary outcomes were estimated cases of measles, rubella, poliomyelitis, and diphtheria in the US. The secondary outcomes were estimated rates of infection-related complications (postmeasles neurological sequelae, congenital rubella syndrome, paralytic poliomyelitis, hospitalization, and death) and the probability and timing for an infection to reestablish endemicity.
At current state-level vaccination rates, the simulation model predicts measles may reestablish endemicity (83% of simulations; mean time of 20.9 years) with an estimated 851 300 cases (95% uncertainty interval [UI], 381 300 to 1.3 million cases) over 25 years. Under a scenario with a 10% decline in measles-mumps-rubella (MMR) vaccination, the model estimates 11.1 million (95% UI, 10.1-12.1 million) cases of measles over 25 years, whereas the model estimates only 5800 cases (95% UI, 3100-19 400 cases) with a 5% increase in MMR vaccination. Other vaccine-preventable diseases are unlikely to reestablish endemicity under current levels of vaccination. If routine childhood vaccination declined by 50%, the model predicts 51.2 million (95% UI, 49.7-52.5 million) cases of measles over a 25-year period, 9.9 million (95% UI, 6.4-13.0 million) cases of rubella, 4.3 million cases (95% UI, 4 cases to 21.5 million cases) of poliomyelitis, and 197 cases (95% UI, 1-1000 cases) of diphtheria. Under this scenario, the model predicts 51 200 cases (95% UI, 49 600-52 600 cases) with postmeasles neurological sequelae, 10 700 cases (95% UI, 6700-14 600 cases) of congenital rubella syndrome, 5400 cases (95% UI, 0-26 300 cases) of paralytic poliomyelitis, 10.3 million hospitalizations (95% UI, 9.9-10.5 million hospitalizations), and 159 200 deaths (95% UI, 151 200-164 700 deaths). In this scenario, measles became endemic at 4.9 years (95% UI, 4.3-5.6 years) and rubella became endemic at 18.1 years (95% UI, 17.0-19.6 years), whereas poliovirus returned to endemic levels in about half of simulations (56%) at an estimated 19.6 years (95% UI, 14.0-24.7 years). There was large variation across the US population.
Based on estimates from this modeling study, declining childhood vaccination rates will increase the frequency and size of outbreaks of previously eliminated vaccine-preventable infections, eventually leading to their return to endemic levels. The timing and critical threshold for returning to endemicity will differ substantially by disease, with measles likely to be the first to return to endemic levels and may occur even under current vaccination levels without improved vaccine coverage and public health response. These findings support the need to continue routine childhood vaccination at high coverage to prevent resurgence of vaccine-preventable infectious diseases in the US.
广泛的儿童疫苗接种已在美国消除了许多传染病。然而,疫苗接种率正在下降,并且目前存在关于减少儿童疫苗接种计划的政策辩论,这可能会使先前已消除的传染病有重新出现的风险。
估计在美国麻疹、风疹、脊髓灰质炎和白喉儿童疫苗接种率下降的情况下的病例数和并发症情况。
设计、设置和参与者:使用模拟模型评估疫苗可预防传染病在美国50个州和哥伦比亚特区的输入和动态传播情况。该模型根据特定地区的人口统计学、人群免疫力和传染病输入风险的估计数据进行参数化设置。该模型评估了25年内不同疫苗接种率的情况。当前儿童疫苗接种率的输入数据基于2004 - 2023年的数据。
主要结果是美国麻疹、风疹、脊髓灰质炎和白喉的估计病例数。次要结果是感染相关并发症(麻疹后神经后遗症、先天性风疹综合征、麻痹性脊髓灰质炎、住院和死亡)的估计发生率以及感染重新建立地方性流行的概率和时间。
按照当前州级疫苗接种率,模拟模型预测麻疹可能会重新建立地方性流行(83%的模拟情况;平均时间为20.9年),在25年内估计有851300例病例(95%不确定区间[UI],381300至130万例)。在麻疹 - 腮腺炎 - 风疹(MMR)疫苗接种率下降10%的情况下,该模型估计25年内有1,110万例(95% UI,1010万至1210万例)麻疹病例,而在MMR疫苗接种率增加5%的情况下,该模型估计仅有5800例(95% UI,3100至19400例)。在当前疫苗接种水平下,其他疫苗可预防疾病不太可能重新建立地方性流行。如果儿童常规疫苗接种率下降50%,该模型预测在25年期间有5120万例(95% UI,4970万至5250万例)麻疹病例、990万例(95% UI,640万至1300万例)风疹病例、430万例(95% UI,4例至2150万例)脊髓灰质炎病例和197例(95% UI,1至1000例)白喉病例。在这种情况下,该模型预测有51200例(95% UI,49600至52600例)麻疹后神经后遗症病例、10700例(95% UI,6700至14600例)先天性风疹综合征病例、5400例(95% UI,0至26300例)麻痹性脊髓灰质炎病例、1030万例住院(95% UI,990万至1050万例住院)和159200例死亡(95% UI,151200至164700例死亡)。在这种情况下,麻疹在4.9年(95% UI,4.3至5.6年)时成为地方性流行,风疹在18.1年(95% UI,17.0至19.6年)时成为地方性流行,而脊髓灰质炎病毒在约一半的模拟情况(56%)中在估计的19.6年(95% UI,14.0至24.7年)时恢复到地方性流行水平。美国不同人群之间存在很大差异。
基于这项建模研究的估计,儿童疫苗接种率下降将增加先前已消除的疫苗可预防感染的暴发频率和规模,最终导致它们恢复到地方性流行水平。恢复到地方性流行的时间和关键阈值因疾病而异,麻疹可能是第一个恢复到地方性流行水平的疾病,甚至在当前疫苗接种水平下,如果疫苗接种覆盖率和公共卫生应对措施没有改善,也可能发生。这些发现支持在美国继续以高覆盖率进行儿童常规疫苗接种以防止疫苗可预防传染病再次流行的必要性。